News

NEWS FROM VIGEO


  • October 15, 2019

    Vigeo Therapeutics to Present at the 2019 BIO Investor Forum

    Read More »


  • September 26, 2019

    Vigeo Therapeutics to Present Results from Its Phase 1 Study Evaluating VT1021 in Patients with Advanced Solid Tumors at the European Society for Medical Oncology (ESMO) 2019 Congress

    Read More »


  • May 31, 2019

    Vigeo Therapeutics Presents Preliminary Results from Its Phase 1 Open Label Trial of VT1021 in Patients with Advanced Solid Tumors at ASCO

    Read More »